a biotechnology company which engages in developing human antibodies for treating infectious diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with SYRS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then SYRS could also see price increases.
Ticker / NAME | Correlation To XFOR | 1D Price Change % | ||
---|---|---|---|---|
XFOR | 100% | -53.17% | ||
SYRS - XFOR | 56% Loosely correlated | -86.85% | ||
KROS - XFOR | 39% Loosely correlated | -2.79% | ||
IMMP - XFOR | 36% Loosely correlated | -5.56% | ||
HOFBF - XFOR | 35% Loosely correlated | N/A | ||
ABSI - XFOR | 34% Loosely correlated | -13.74% | ||
More |
Ticker / NAME | Correlation To XFOR | 1D Price Change % |
---|---|---|
XFOR | 100% | -53.17% |
drugs theme (254 stocks) | 24% Poorly correlated | -1.72% |
diseases theme (41 stocks) | 21% Poorly correlated | -1.18% |
biotechnology theme (238 stocks) | 19% Poorly correlated | -1.80% |
human theme (15 stocks) | 14% Poorly correlated | +1.86% |